| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gossamer Bio, Inc. (GOSS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. GOSS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 837.8K | $274.0K | - | |
| VP | 814.1K | $266.2K | - | |
| Other | 562.5K | $183.9K | - | |
| Other | 463.1K | $151.4K | - | |
| CFO | 389.7K | $127.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2022 | Hasnain Faheem74 | President &CEO | Sell | 19,035 | $8.92 | $169,697.03 | -11.7% | -20.1% | -87.8% | |
| Mar 23, 2022 | Christian Waage75 | EVP, Tech Ops And Admin | Sell | 10,722 | $8.92 | $95,586.63 | -1.8% | -20.1% | -87.8% | |
| Mar 23, 2022 | Giraudo Bryan73 | Coo/ CFO | Sell | 10,722 | $8.92 | $95,586.63 | -9.8% | -20.1% | -87.8% | |
| Mar 16, 2022 | Carter Laura64 | Chief Scientific Officer | Sell | 5,002 | $8.28 | $41,406.56 | -5.2% | -30.5% | -87.8% | |
| Mar 16, 2022 | Peterson Caryn63 | EVP, Regulatory Affairs | Sell | 6,279 | $8.28 | $51,977.56 | -8.7% | -30.5% | -87.8% | |
| Mar 16, 2022 | Aranda Richard66 | Chief Medical Officer | Sell | 6,278 | $8.28 | $51,975.56 | -2.9% | -30.5% | -87.8% | |
| Oct 25, 2021 | Peterson Caryn63 | EVP, Regulatory Affairs | Sell | 2,377 | $12.25 | $29,118.25 | -3.2% | -19.3% | -6.2% | |
| Oct 25, 2021 | Carter Laura64 | Chief Scientific Officer | Sell | 2,377 | $12.25 | $29,118.25 | -2.4% | -19.3% | -6.2% | |
| Oct 25, 2021 | Aranda Richard66 | Chief Medical Officer | Sell | 2,377 | $12.25 | $29,118.25 | -1.1% | -19.3% | -6.2% | |
| Mar 23, 2021 | Salter-Cid Luisa | Chief Scientific Officer | Sell | 5,491 | $9.48 | $52,051.93 | -2.6% | -7.0% | -3.4% |